Business Standard
Saturday, Feb 04, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
  Home  ||||||||| 
 BS Headlines | News Now | BS Weekend | The strategist | smartinvestor.in | E-Paper | SME | B-School | Run-up to Budget | Energy | Have Your Say | B-School Award
Home > Live Markets | Commodities
 

Metropolis Health Services gets approval for H1N1 testing
Announcement / Corporate Sep 18, 2009, 16:31 IST

Tamil Nadu State Government approves Lister Metropolis to conduct H1N1 screenings

Lister Metropolis, a part of Metropolis Health Services- India’s only multinational chain of diagnostics centre has received authorization from Tamil Nadu state government to initiate H1N1 testing for Swine Flu. Lister Metropolis has successfully cleared all safety norms specified by the state government. Metropolis Labs in Mumbai and Pune have also applied for conducting H1N1 and are waiting for the government approvals for the same

On the occasion, Dr. GSK Velu, Managing Director- Metropolis Health Services says, “The scourge of Swine flu has affected 100s of people across the nation. Post this approval from the Tamil Nadu government, we at Metropolis, are fully geared for the testing of as many patients as possible for the H1N1 screening. Metropolis labs in Mumbai and Pune are also fully prepared for H1N1 testing and eagerly await government approval. ” Metropolis Health Services has the maximum number of accreditation, making it one of the most trusted labs not only in India but also amongst the international fraternity. Besides CAP, NABL and ISO, Metropolis is the first laboratory to receive SANAS an accreditation given for the first time to any international laboratory in South Africa.

“Special room and trained staff have been arranged for the H1N1 testing. Complete Personal Protection Equipment (PPE) has been provided for all involved. We are using the RT PCR method and approved tests and kits. We have also set up a separate MIS system for patients’ registration, thus creating an independent database for all H1N1 testing taking place.” says Dr. Anitha Suryanarayan, Chief of Laboratories- Metropolis Health Services.

In order to avoid any sort of mixing with the general public, Lister Metropolis has created a special room for all H1N1 testing to take place. This room is non air conditioned with a separate entry and exit. The sample collection is done through a window to reduce contact and waste disposal has been managed according to the rules mentioned by the government. Staff comprising of technicians and micro biologists have been specially trained for the screening process. Physician is present in the premise for walk in patients and a special discounted rate can be availed by all referrals from government hospitals. Lister Metropolis has also facilitated a specially trained collections team for Home Health Services where all samples are travelling straight time. H1N1 testing is conducted between 12pm to 4pm from Monday- Saturday.

About Metropolis Health Services:

Metropolis Health Services (I) Ltd. was founded by Dr. Sushil Shah in 1981. Metropolis Health Services is India’s only multinational chain of diagnostic center with global presence in Srilanka, UAE, South Africa and Seychelles. It provides over 3600 specialized tests under a single roof ranging from oncology to genetics, molecular biology and immunoassays using best-of-breed and latest diagnostic equipment. Metropolis is a preferred referral center for more than 20,000 laboratories, clinicians, hospitals and research institutions across the nation. The CAP and NABL accredited and ISO 9002 certified Metropolis chain of laboratories has over 350 franchisees and is a preferred partner for providing quality testing to over 10,000-referral network across the country. Services include Clinical Laboratory Medicine, Radiology & Imaging Services, Hospital Laboratory Management, Central Laboratory Services for Clinical Trials, Site Management Services, Home Health Services, Preventive Health Check ups and Remote Pathology Testing Services.

 

 

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Wall Street gains 1% on jobs jump
- PEs may hang up on telecom in short-term, post SC vedict
- Telenor to write down $721 mn on licences in India
- Tata Tele Q3 net loss at Rs 144 cr
- Ex-UBS trader refused bail as bank probe deepens
  Read Business news in 
Sorry, comments to this story are closed
Latest Messages
SmartInvestor+ E-zine
  Pay Rs.747/- for 3 years and
  get a branded watch FREE

  Subscribe Now
Most Popular
Read
E-Mailed
Commented
   
- Bharti: Pricing freedom to return
- SC breather for Army Chief
- Adman Turned Ad Entrepreneur
- Madan Sabnavis: 2012 - The year for commodities?
- Fear factor
 
 More  
BUSINESS STANDARD INDIA 2012
  Now available at Special price
  Rs.395/- Only

  Buy Now
  BS Specials  
    Full coverage of elections in Uttar Pradesh, Punjab, Uttarakhand, Manipur and Goa
  Hot Searches  
 
Ambassador car |  Uttarakhand |  TCS |  Sarfaesi Act |  Vodafone |  DZire |  Aakash tablet |  Sodexo |  NHAI |  Companies Bill 2011 |  Playbook |  Rupee |  Samsung Galaxy Note |  Kingfisher Airlines |  FDI in retail |  Silver |  Provident Fund |  income tax refund |  Anna Hazare |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  TCS |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us